You can read Premium News stories in full if you have an Annual Subscription to the OTCToolbox website. You can read Basic News stories free of charge.
3 March 2020
Sanofi Consumer Healthcare’s deal for exclusive OTC rights to Roche’s Tamiflu (oseltamivir) in the US has won the OTCToolbox Consumer Healthcare Industry (CHi) Award for Transaction of the Year.
3 March 2020
Sanofi plans to create a European active pharmaceutical ingredients (API) supplier, Abbvie has provided an update on its planned takeover of Allergan, and Adcock Ingram has released financial results.
12 February 2020
Sanofi's Consumer Healthcare business reported worldwide sales down by 5.2% at constant exchange rates in the fourth quarter of 2019. The company said the fall was due to the voluntary recall of Zantac (ranitidine), non-core brand divestments, and product suspensions due to changing regulatory requi...
10 December 2019
Sanofi’s new chief executive officer Paul Hudson is restructuring the company into three “core” global business units and a “standalone” Consumer Healthcare operation.
25 November 2019
Media reports suggest Sanofi is considering a range of strategic options, including divestment, for its Consumer Healthcare business, but no final decision has been made.
15 November 2019
Sanofi Consumer Healthcare has an option on technology from ResApp Health, which is developing smartphone applications for the diagnosis and management of respiratory disease.
8 November 2019
Sanofi's Consumer Healthcare business reported worldwide sales up by 0.4% at constant exchange rates in the third quarter of 2019. The company said growth had been curbed by a voluntary recall of Zantac, non-core brand divestments, and tightening regulatory requirements, particularly in Europe.
2 September 2019
Italy's Angelini Pharma has acquired two brands from Sanofi Consumer Healthcare in Germany and Austria for EUR47 million (USD51 million).
5 August 2019
Sanofi's Consumer Healthcare business reported worldwide sales up by 1.1% at constant exchange rates in the second quarter of 2019. The company said brand divestments and tightening regulatory requirements, particularly in Europe, had reduced growth by around two percentage points.
23 July 2019
Sanofi has gained exclusive OTC rights to Roche's Tamiflu (oseltamivir) for prevention and treatment of flu in the US.